Evidence map›Paper›PMID 19716396›Full record

ReviewAdvanced drug delivery reviews2009

Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactions.

Valerian E Kagan, Peter Wipf, Detcho Stoyanovsky, Joel S Greenberger, Grigory Borisenko, Natalia A Belikova, Naveena Yanamala, Alejandro K Samhan Arias, Muhammad A Tungekar, Jianfei Jiang and 6 more

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 118 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. An Overview: The Diversified Role of Mitochondria in Cancer Metabolism.International journal of biological sciences · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Role of Cardiolipin and Mitochondrial Damage in Kidney Transplant.Oxidative medicine and cellular longevity · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Valerian E KaganCenter for Free Radical and Antioxidant Health, University of Pittsburgh, PA 15219, USA. kagan@pitt.edu
Peter Wipf
Detcho Stoyanovsky
Joel S Greenberger
Grigory Borisenko
Natalia A Belikova
Naveena Yanamala
Alejandro K Samhan Arias
Muhammad A Tungekar
Jianfei Jiang
Yulia Y Tyurina
Jing Ji
Judith Klein-Seetharaman
Bruce R Pitt
Anna A Shvedova
Hülya Bayir
University of Pittsburgh · USPhysico-Technical Institute · RU

Funding

Training and EducationU19AI068021 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GREENBERGER, JOEL S · 2005 to 2019
$44.4M
Oxidative Lipidomics in Pediatric Traumatic Brain InjuryR01NS061817 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAYIR, HÜLYA · 2008 to 2018
$3.3M
Pulmonary Phosphatidylserine Oxidation in ApoptosisR01HL070755 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAGAN, VALERIAN E · 2002 to 2011
$3.0M
Oxidative Lipidomics in Pediatric Traumatic Brain InjuryR37NS061817 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Hülya Bayir · 2021 to 2026
$2.2M
Role of Cardiolipin Oxidation After Traumatic Brain Injury in Immature RatR21HD057587 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAYIR, HÜLYA · 2007 to 2009
$458k
NHLBI NIH HHS HL70755NHLBI NIH HHS R01 HL070755NIAID NIH HHS U19 AI068021NICHD NIH HHS HD057587NICHD NIH HHS R21 HD057587NINDS NIH HHS NS061817NINDS NIH HHS R01 NS061817NINDS NIH HHS R37 NS061817PHS HHS U19 AIO68021
6 · The paper itself

Abstract

Effective regulation of highly compartmentalized production of reactive oxygen species and peroxidation reactions in mitochondria requires targeting of small molecule antioxidants and antioxidant enzymes into the organelles. This review describes recently developed approaches to mitochondrial targeting of small biologically active molecules based on: (i) preferential accumulation in mitochondria because of their hydrophobicity and positive charge (hydrophobic cations), (ii) binding with high affinity to an intra-mitochondrial constituent, and (iii) metabolic conversions by specific mitochondrial enzymes to reveal an active entity. In addition, targeted delivery of antioxidant enzymes via expression of leader sequences directing the proteins into mitochondria is considered. Examples of successful antioxidant and anti-apoptotic protection based on the ability of targeted cargoes to inhibit cytochrome c-catalyzed peroxidation of a mitochondria-specific phospholipid cardiolipin, in vitro and in vivo are presented. Particular emphasis is placed on the employment of triphenylphosphonium- and hemi-gramicidin S-moieties as two effective vehicles for mitochondrial delivery of antioxidants.

Indexed as

AnimalsAntioxidantsApoptosisDrug Delivery SystemsElectron Transport Complex IFree Radical ScavengersHumansMitochondriaModels, BiologicalMolecular StructureOxidation-ReductionOxidative StressReactive Oxygen SpeciesAntioxidantsElectron Transport Complex IFree Radical ScavengersReactive Oxygen Species

Identifiers

PMID19716396
PMCPMC2784017
OpenAlexW2035351765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.